A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Odalasvir and AL-335 Alone and in Combination With Simeprevir in Participants With Moderately Impaired Hepatic Function
Clinical trial NCT03277755 · WITHDRAWN
Trial details
- NCT number
- NCT03277755
- Sponsor
- Janssen Research & Development, LLC
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-11
- Primary completion
- 2017-12-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.